Copyright Reports & Markets. All rights reserved.

Global Label-Free Drug Discovery Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Label-Free Drug Discovery
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Label-Free Drug Discovery by Type
    • 1.3.1 Overview: Global Label-Free Drug Discovery Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Label-Free Drug Discovery Consumption Value Market Share by Type in 2023
    • 1.3.3 Cellular Dielectric Spectroscopy
    • 1.3.4 Bio-layer Interferometry
    • 1.3.5 Surface Plasmon Resonance
    • 1.3.6 Optical Waveguide Grating Technology
  • 1.4 Global Label-Free Drug Discovery Market by Application
    • 1.4.1 Overview: Global Label-Free Drug Discovery Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Pharmaceutical Companies
    • 1.4.3 Research Laboratories
    • 1.4.4 Other
  • 1.5 Global Label-Free Drug Discovery Market Size & Forecast
  • 1.6 Global Label-Free Drug Discovery Market Size and Forecast by Region
    • 1.6.1 Global Label-Free Drug Discovery Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Label-Free Drug Discovery Market Size by Region, (2019-2030)
    • 1.6.3 North America Label-Free Drug Discovery Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Label-Free Drug Discovery Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Label-Free Drug Discovery Market Size and Prospect (2019-2030)
    • 1.6.6 South America Label-Free Drug Discovery Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Label-Free Drug Discovery Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Thermo Fisher Scientific
    • 2.1.1 Thermo Fisher Scientific Details
    • 2.1.2 Thermo Fisher Scientific Major Business
    • 2.1.3 Thermo Fisher Scientific Label-Free Drug Discovery Product and Solutions
    • 2.1.4 Thermo Fisher Scientific Label-Free Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.2 GE Healthcare
    • 2.2.1 GE Healthcare Details
    • 2.2.2 GE Healthcare Major Business
    • 2.2.3 GE Healthcare Label-Free Drug Discovery Product and Solutions
    • 2.2.4 GE Healthcare Label-Free Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 GE Healthcare Recent Developments and Future Plans
  • 2.3 Corning
    • 2.3.1 Corning Details
    • 2.3.2 Corning Major Business
    • 2.3.3 Corning Label-Free Drug Discovery Product and Solutions
    • 2.3.4 Corning Label-Free Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Corning Recent Developments and Future Plans
  • 2.4 Albany Molecular Research, Inc (AMRI)
    • 2.4.1 Albany Molecular Research, Inc (AMRI) Details
    • 2.4.2 Albany Molecular Research, Inc (AMRI) Major Business
    • 2.4.3 Albany Molecular Research, Inc (AMRI) Label-Free Drug Discovery Product and Solutions
    • 2.4.4 Albany Molecular Research, Inc (AMRI) Label-Free Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Albany Molecular Research, Inc (AMRI) Recent Developments and Future Plans
  • 2.5 Charles River Laboratories
    • 2.5.1 Charles River Laboratories Details
    • 2.5.2 Charles River Laboratories Major Business
    • 2.5.3 Charles River Laboratories Label-Free Drug Discovery Product and Solutions
    • 2.5.4 Charles River Laboratories Label-Free Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Charles River Laboratories Recent Developments and Future Plans
  • 2.6 Evotec
    • 2.6.1 Evotec Details
    • 2.6.2 Evotec Major Business
    • 2.6.3 Evotec Label-Free Drug Discovery Product and Solutions
    • 2.6.4 Evotec Label-Free Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Evotec Recent Developments and Future Plans
  • 2.7 Jubilant Biosys
    • 2.7.1 Jubilant Biosys Details
    • 2.7.2 Jubilant Biosys Major Business
    • 2.7.3 Jubilant Biosys Label-Free Drug Discovery Product and Solutions
    • 2.7.4 Jubilant Biosys Label-Free Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Jubilant Biosys Recent Developments and Future Plans
  • 2.8 WuXi AppTec
    • 2.8.1 WuXi AppTec Details
    • 2.8.2 WuXi AppTec Major Business
    • 2.8.3 WuXi AppTec Label-Free Drug Discovery Product and Solutions
    • 2.8.4 WuXi AppTec Label-Free Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 WuXi AppTec Recent Developments and Future Plans
  • 2.9 Agilent
    • 2.9.1 Agilent Details
    • 2.9.2 Agilent Major Business
    • 2.9.3 Agilent Label-Free Drug Discovery Product and Solutions
    • 2.9.4 Agilent Label-Free Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Agilent Recent Developments and Future Plans
  • 2.10 SAMDI Tech
    • 2.10.1 SAMDI Tech Details
    • 2.10.2 SAMDI Tech Major Business
    • 2.10.3 SAMDI Tech Label-Free Drug Discovery Product and Solutions
    • 2.10.4 SAMDI Tech Label-Free Drug Discovery Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 SAMDI Tech Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Label-Free Drug Discovery Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Label-Free Drug Discovery by Company Revenue
    • 3.2.2 Top 3 Label-Free Drug Discovery Players Market Share in 2023
    • 3.2.3 Top 6 Label-Free Drug Discovery Players Market Share in 2023
  • 3.3 Label-Free Drug Discovery Market: Overall Company Footprint Analysis
    • 3.3.1 Label-Free Drug Discovery Market: Region Footprint
    • 3.3.2 Label-Free Drug Discovery Market: Company Product Type Footprint
    • 3.3.3 Label-Free Drug Discovery Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Label-Free Drug Discovery Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Label-Free Drug Discovery Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Label-Free Drug Discovery Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Label-Free Drug Discovery Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Label-Free Drug Discovery Consumption Value by Type (2019-2030)
  • 6.2 North America Label-Free Drug Discovery Consumption Value by Application (2019-2030)
  • 6.3 North America Label-Free Drug Discovery Market Size by Country
    • 6.3.1 North America Label-Free Drug Discovery Consumption Value by Country (2019-2030)
    • 6.3.2 United States Label-Free Drug Discovery Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Label-Free Drug Discovery Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Label-Free Drug Discovery Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Label-Free Drug Discovery Consumption Value by Type (2019-2030)
  • 7.2 Europe Label-Free Drug Discovery Consumption Value by Application (2019-2030)
  • 7.3 Europe Label-Free Drug Discovery Market Size by Country
    • 7.3.1 Europe Label-Free Drug Discovery Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Label-Free Drug Discovery Market Size and Forecast (2019-2030)
    • 7.3.3 France Label-Free Drug Discovery Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Label-Free Drug Discovery Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Label-Free Drug Discovery Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Label-Free Drug Discovery Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Label-Free Drug Discovery Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Label-Free Drug Discovery Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Label-Free Drug Discovery Market Size by Region
    • 8.3.1 Asia-Pacific Label-Free Drug Discovery Consumption Value by Region (2019-2030)
    • 8.3.2 China Label-Free Drug Discovery Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Label-Free Drug Discovery Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Label-Free Drug Discovery Market Size and Forecast (2019-2030)
    • 8.3.5 India Label-Free Drug Discovery Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Label-Free Drug Discovery Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Label-Free Drug Discovery Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Label-Free Drug Discovery Consumption Value by Type (2019-2030)
  • 9.2 South America Label-Free Drug Discovery Consumption Value by Application (2019-2030)
  • 9.3 South America Label-Free Drug Discovery Market Size by Country
    • 9.3.1 South America Label-Free Drug Discovery Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Label-Free Drug Discovery Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Label-Free Drug Discovery Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Label-Free Drug Discovery Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Label-Free Drug Discovery Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Label-Free Drug Discovery Market Size by Country
    • 10.3.1 Middle East & Africa Label-Free Drug Discovery Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Label-Free Drug Discovery Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Label-Free Drug Discovery Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Label-Free Drug Discovery Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Label-Free Drug Discovery Market Drivers
  • 11.2 Label-Free Drug Discovery Market Restraints
  • 11.3 Label-Free Drug Discovery Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Label-Free Drug Discovery Industry Chain
  • 12.2 Label-Free Drug Discovery Upstream Analysis
  • 12.3 Label-Free Drug Discovery Midstream Analysis
  • 12.4 Label-Free Drug Discovery Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Label-Free Drug Discovery market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
    In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new candidate medications are discovered. Drug Discovery Service are specifically designed to minimize the costs and timelines of drug discovery.Skipping the tedious labeling and optimization steps required by other drug screening technologies, the label-free method eliminates the long time, higher cost and false positive results required by traditional detection methods.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    The Global Info Research report includes an overview of the development of the Label-Free Drug Discovery industry chain, the market status of Pharmaceutical Companies (Cellular Dielectric Spectroscopy, Bio-layer Interferometry), Research Laboratories (Cellular Dielectric Spectroscopy, Bio-layer Interferometry), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Label-Free Drug Discovery.
    Regionally, the report analyzes the Label-Free Drug Discovery markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Label-Free Drug Discovery market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Label-Free Drug Discovery market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Label-Free Drug Discovery industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Cellular Dielectric Spectroscopy, Bio-layer Interferometry).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Label-Free Drug Discovery market.
    Regional Analysis: The report involves examining the Label-Free Drug Discovery market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Label-Free Drug Discovery market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Label-Free Drug Discovery:
    Company Analysis: Report covers individual Label-Free Drug Discovery players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Label-Free Drug Discovery This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Pharmaceutical Companies, Research Laboratories).
    Technology Analysis: Report covers specific technologies relevant to Label-Free Drug Discovery. It assesses the current state, advancements, and potential future developments in Label-Free Drug Discovery areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Label-Free Drug Discovery market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Label-Free Drug Discovery market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
    Market segment by Type
    Cellular Dielectric Spectroscopy
    Bio-layer Interferometry
    Surface Plasmon Resonance
    Optical Waveguide Grating Technology
    Market segment by Application
    Pharmaceutical Companies
    Research Laboratories
    Other
    Market segment by players, this report covers
    Thermo Fisher Scientific
    GE Healthcare
    Corning
    Albany Molecular Research, Inc (AMRI)
    Charles River Laboratories
    Evotec
    Jubilant Biosys
    WuXi AppTec
    Agilent
    SAMDI Tech
    Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Label-Free Drug Discovery product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Label-Free Drug Discovery, with revenue, gross margin and global market share of Label-Free Drug Discovery from 2019 to 2024.
    Chapter 3, the Label-Free Drug Discovery competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Label-Free Drug Discovery market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Label-Free Drug Discovery.
    Chapter 13, to describe Label-Free Drug Discovery research findings and conclusion.

    Buy now